News Archives - Page 158 of 1183 - BioHealth Innovation

News

March 14, 2022

Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk

Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Joins BioTalk to discuss his career path, loving Baltimore, and…

admin

Love0

News

March 14, 2022

Novavax Announces Launch of Global Vaccine Education Programs

- 'We Do Vaccines' and 'Know Our Vax' are new educational efforts that provide information regarding vaccines - Programs explain Novavax' commitment…

admin

Love0

News

March 14, 2022

Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning

GAITHERSBURG, Md., March 11, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in its…

admin

Love0

News

March 13, 2022

Stonebridge Plans 800K SF Of Life Sciences Development In Montgomery County

The Bethesda-based developer is preparing two developments under the moniker "EvolutionLabs" to take advantage of the growing life sciences demand in the…

admin

Love0

News

March 13, 2022

Medical device companies find an ideal home in the UM BioPark – Technical.ly

In 2003, a group of University of Maryland officials approached then-mayor Martin O’Malley with a development plan for vacant land…

admin

Love0

News

March 13, 2022

Johns Hopkins, University of Maryland Medical System to send $4 million in medical supplies to Ukraine

BALTIMORE — The University of Maryland Medical System and Johns Hopkins Medicine have announced they will send more than $4…

admin

Love0

Marty Rosendale, CEO of the Maryland Tech Council, said the organization created regional chapters

News

March 13, 2022

Maryland Inno – Maryland Tech Council takes regional approach with launch of new chapters

The Maryland Tech Council has launched two new regional satellite chapters to directly focus on the burgeoning technology sectors in…

admin

Love0

News

March 13, 2022

Bispecific antiviral neutralizing antibodies are twice as nice | Nature Immunology

Human monoclonal antibodies (mAbs) are being used in the clinic to prevent or treat SARS-CoV-2 infection, and experience thus far…

admin

Love0

News

March 13, 2022

Emmes Acquires Casimir, Its Fourth Major Acquisition

Casimir Further Differentiates Emmes' Industry-Leading Rare Disease Research Capabilities ROCKVILLE, Md., March 10, 2022 /PRNewswire/ -- Emmes, a global, full-service…

admin

Love0

News

March 13, 2022

Gaithersburg’s Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases

– Reports Promising Early Data from Lead Clinical Program, JK07, for the Treatment of Heart Failure with Reduced Ejection Fraction – – Initiates…

admin

Love0

News

Dr. Ken Malone, Co-Founder and Managing Director of Early Charm Ventures, Visits BioTalk

Novavax Announces Launch of Global Vaccine Education Programs

Emergent BioSolutions Initiates Phase 1 Study Evaluating Potential Intranasal Treatment for Cyanide Poisoning

Stonebridge Plans 800K SF Of Life Sciences Development In Montgomery County

Medical device companies find an ideal home in the UM BioPark – Technical.ly

Johns Hopkins, University of Maryland Medical System to send $4 million in medical supplies to Ukraine

Maryland Inno – Maryland Tech Council takes regional approach with launch of new chapters

Bispecific antiviral neutralizing antibodies are twice as nice | Nature Immunology

Emmes Acquires Casimir, Its Fourth Major Acquisition

Gaithersburg’s Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search